We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New Drug Delivery System Targets Diseases at a Genetic Level

News   Dec 06, 2017 | Original story from University of Connecticut

 
New Drug Delivery System Targets Diseases at a Genetic Level

Enzyme-triggered degradation of a drug loaded peptide-crosslinked nucleic acid nanocapsule. First a peptide is crosslinked at the nanoparticle surface (1), then an enzyme recognizes the peptide crosslinker (2), and finally the enzyme cleavage leads to the release of the drug and any intact DNA (3). Credit: (Artwork by Joseph Luciani/UConn)

 
 
 

RELATED ARTICLES

Sequencing Offers New Hope for Rare Cancers

News

A cancer’s genetic sequence may be the key to matching people with rare cancers to the right anti-cancer treatments, according to a new clinical trial instigated by patients.

READ MORE

Revealed: How Deadly Pneumococcus Suppresses Immune Defenses

News

Scientists have discovered a new and important function of a toxin produced by disease-causing bacteria that could have significant implications for future vaccine design.

READ MORE

Personalized Implants Designed to Improve Organ Transplant Success

News

Host-derived scaffolding material may reduce the chance of organ transplant rejection.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE